Ginsenoside Re Inhibits NLRP3 Inflammasome Activation in Depressive Mice by Promoting PINK1-Mediated Mitophagy

Shan Liu1, Yue Zhang2, Hao Zhou2

  • 1Department of Physiology, School of Basic Medical Science, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, Anhui 233000, China.

Insights

Ginsenoside Re improves depression by enhancing mitophagy via PINK1 and reducing NLRP3 inflammasome activation. This study reveals a key mechanism for its antidepressant effects.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Ginsenoside Re (Re) shows antidepressant potential, but its mechanism is unclear.
  • Depression is linked to neuroinflammation and mitochondrial dysfunction.

Purpose of the Study:

  • To investigate the antidepressant mechanism of Ginsenoside Re.
  • To explore the roles of PTEN-induced putative kinase 1 (PINK1)-mediated mitophagy and NLRP3 inflammasomes in Re's effects.

Main Methods:

  • Chronic unpredictable mild stress (CUMS) mouse model and lipopolysaccharide (LPS)-stimulated astrocytes were used.
  • RNA sequencing, bioinformatics analysis, and PINK1 knockdown were performed.

Main Results:

  • Ginsenoside Re ameliorated depressive-like behaviors in CUMS mice.
  • Re activated PINK1-mediated mitophagy and inhibited NLRP3 inflammasome activation in astrocytes.
  • PINK1 knockdown reversed the antidepressant effects of Re and its impact on mitophagy and inflammasomes.

Conclusions:

  • Ginsenoside Re exerts antidepressant effects by promoting PINK1-mediated mitophagy.
  • This process subsequently inhibits NLRP3 inflammasome activation, offering a novel therapeutic target.